ALT logo

Altimmune (ALT) Net Income

Annual Net Income

-$88.45 M
-$3.73 M-4.41%

December 31, 2023


Summary


Performance

ALT Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALTprofitabilitymetrics:

Quarterly Net Income

-$22.84 M
+$1.79 M+7.28%

September 30, 2024


Summary


Performance

ALT Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALTprofitabilitymetrics:

TTM Net Income

-$103.52 M
-$2.17 M-2.15%

September 30, 2024


Summary


Performance

ALT TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALTprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

ALT Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-4.4%+27.8%-17.0%
3 y3 years-80.3%+31.8%-23.5%
5 y5 years-125.8%-108.8%-404.5%

ALT Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-4.4%+8.9%-42.2%+27.8%-31.9%at low
5 y5-year-331.0%+8.9%-487.9%+31.8%-404.5%at low
alltimeall time<-9999.0%+8.9%-1661.1%+31.8%<-9999.0%at low

Altimmune Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$22.84 M(-7.3%)
-$103.52 M(+2.1%)
Jun 2024
-
-$24.64 M(+1.0%)
-$101.35 M(+9.2%)
Mar 2024
-
-$24.39 M(-22.9%)
-$92.77 M(+4.9%)
Dec 2023
-$88.45 M(+4.4%)
-$31.64 M(+53.1%)
-$88.45 M(+12.7%)
Sep 2023
-
-$20.67 M(+28.7%)
-$78.47 M(-3.5%)
Jun 2023
-
-$16.06 M(-20.0%)
-$81.31 M(-4.7%)
Mar 2023
-
-$20.07 M(-7.3%)
-$85.36 M(+0.8%)
Dec 2022
-$84.71 M(-12.7%)
-$21.66 M(-7.9%)
-$84.71 M(-2.6%)
Sep 2022
-
-$23.52 M(+17.0%)
-$86.94 M(-10.3%)
Jun 2022
-
-$20.11 M(+3.5%)
-$96.94 M(-4.6%)
Mar 2022
-
-$19.43 M(-18.7%)
-$101.66 M(+4.7%)
Dec 2021
-$97.09 M(+98.0%)
-$23.89 M(-28.7%)
-$97.09 M(+15.8%)
Sep 2021
-
-$33.51 M(+35.0%)
-$83.82 M(+23.1%)
Jun 2021
-
-$24.83 M(+67.0%)
-$68.08 M(+13.4%)
Mar 2021
-
-$14.86 M(+39.9%)
-$60.02 M(+22.4%)
Dec 2020
-$49.04 M(+139.0%)
-$10.62 M(-40.2%)
-$49.04 M(+15.3%)
Sep 2020
-
-$17.77 M(+6.0%)
-$42.52 M(+19.1%)
Jun 2020
-
-$16.77 M(+331.5%)
-$35.69 M(+60.0%)
Mar 2020
-
-$3.89 M(-5.2%)
-$22.31 M(+8.7%)
Dec 2019
-$20.52 M(-47.6%)
-$4.10 M(-62.6%)
-$20.52 M(-49.9%)
Sep 2019
-
-$10.94 M(+223.0%)
-$40.93 M(+26.6%)
Jun 2019
-
-$3.39 M(+61.5%)
-$32.34 M(-15.1%)
Mar 2019
-
-$2.10 M(-91.4%)
-$38.09 M(-2.7%)
Dec 2018
-$39.17 M(-15.6%)
-$24.51 M(+942.4%)
-$39.17 M(+66.7%)
Sep 2018
-
-$2.35 M(-74.3%)
-$23.49 M(-54.0%)
Jun 2018
-
-$9.14 M(+188.0%)
-$51.05 M(+13.4%)
Mar 2018
-
-$3.17 M(-64.1%)
-$45.02 M(-3.0%)
Dec 2017
-$46.43 M(+318.7%)
-$8.83 M(-70.5%)
-$46.43 M(+14.2%)
Sep 2017
-
-$29.91 M(+861.5%)
-$40.66 M(+161.5%)
Jun 2017
-
-$3.11 M(-32.1%)
-$15.55 M(+10.6%)
Mar 2017
-
-$4.58 M(+49.5%)
-$14.05 M(+31.3%)
Dec 2016
-$11.09 M(+222.2%)
-$3.06 M(-36.1%)
-$10.70 M(+20.5%)
Sep 2016
-
-$4.80 M(+196.5%)
-$8.88 M(+64.2%)
Jun 2016
-
-$1.62 M(+31.8%)
-$5.41 M(-11.8%)
Mar 2016
-
-$1.23 M(-0.9%)
-$6.13 M(+78.2%)
Dec 2015
-$3.44 M
-$1.24 M(-6.5%)
-$3.44 M(-28.8%)
Sep 2015
-
-$1.32 M(-43.4%)
-$4.83 M(-40.6%)
Jun 2015
-
-$2.34 M(-260.0%)
-$8.14 M(+30.5%)
DateAnnualQuarterlyTTM
Mar 2015
-
$1.46 M(-155.7%)
-$6.23 M(-37.4%)
Dec 2014
-$9.96 M(-15.0%)
-$2.63 M(-43.2%)
-$9.96 M(-15.3%)
Sep 2014
-
-$4.63 M(+954.1%)
-$11.75 M(+6.2%)
Jun 2014
-
-$439.10 K(-80.6%)
-$11.07 M(-6.7%)
Mar 2014
-
-$2.26 M(-49.0%)
-$11.87 M(+1.3%)
Dec 2013
-$11.72 M(+138.2%)
-$4.42 M(+12.1%)
-$11.72 M(+36.8%)
Sep 2013
-
-$3.95 M(+219.1%)
-$8.56 M(+77.2%)
Jun 2013
-
-$1.24 M(-41.4%)
-$4.83 M(+11.0%)
Mar 2013
-
-$2.11 M(+66.3%)
-$4.35 M(-11.6%)
Dec 2012
-$4.92 M(+29.6%)
-$1.27 M(+493.6%)
-$4.92 M(+69.6%)
Sep 2012
-
-$213.90 K(-71.7%)
-$2.90 M(+6.6%)
Jun 2012
-
-$756.50 K(-71.8%)
-$2.72 M(-38.2%)
Mar 2012
-
-$2.68 M(-457.7%)
-$4.40 M(+15.9%)
Dec 2011
-$3.80 M(-89.1%)
$749.20 K(-2336.4%)
-$3.80 M(-81.7%)
Sep 2011
-
-$33.50 K(-98.6%)
-$20.73 M(-17.2%)
Jun 2011
-
-$2.44 M(+17.4%)
-$25.03 M(-13.6%)
Mar 2011
-
-$2.08 M(-87.2%)
-$28.98 M(-16.8%)
Dec 2010
-$34.85 M(+8.0%)
-$16.18 M(+273.9%)
-$34.85 M(+43.2%)
Sep 2010
-
-$4.33 M(-32.3%)
-$24.34 M(-28.4%)
Jun 2010
-
-$6.39 M(-19.5%)
-$33.97 M(-0.7%)
Mar 2010
-
-$7.94 M(+40.1%)
-$34.21 M(+6.0%)
Dec 2009
-$32.28 M(-11.4%)
-$5.67 M(-59.4%)
-$32.28 M(+1.5%)
Sep 2009
-
-$13.96 M(+110.5%)
-$31.81 M(+43.4%)
Jun 2009
-
-$6.63 M(+10.3%)
-$22.19 M(-40.7%)
Mar 2009
-
-$6.01 M(+15.6%)
-$37.41 M(+2.7%)
Dec 2008
-$36.42 M(+168.0%)
-$5.20 M(+19.8%)
-$36.42 M(+0.3%)
Sep 2008
-
-$4.34 M(-80.1%)
-$36.31 M(+12.5%)
Jun 2008
-
-$21.85 M(+335.5%)
-$32.29 M(+203.3%)
Mar 2008
-
-$5.02 M(-1.6%)
-$10.64 M(+24.4%)
Dec 2007
-$13.59 M(-10.2%)
-$5.10 M(+1509.1%)
-$8.56 M(+0.8%)
Sep 2007
-
-$316.90 K(+50.0%)
-$8.48 M(-28.3%)
Jun 2007
-
-$211.30 K(-92.8%)
-$11.83 M(+4.4%)
Mar 2007
-
-$2.93 M(-41.8%)
-$11.34 M(+38.2%)
Dec 2006
-$15.13 M(-5557.4%)
-$5.03 M(+37.2%)
-$8.20 M(+169.6%)
Sep 2006
-
-$3.66 M(-1390.8%)
-$3.04 M(-496.2%)
Jun 2006
-
$283.90 K(+38.9%)
$768.10 K(+58.6%)
Mar 2006
-
$204.40 K(+53.3%)
$484.20 K(+73.1%)
Dec 2005
$277.30 K
$133.30 K(-9.0%)
$279.80 K(+91.0%)
Sep 2005
-
$146.50 K
$146.50 K

FAQ

  • What is Altimmune annual net profit?
  • What is the all time high annual net income for Altimmune?
  • What is Altimmune annual net income year-on-year change?
  • What is Altimmune quarterly net profit?
  • What is the all time high quarterly net income for Altimmune?
  • What is Altimmune quarterly net income year-on-year change?
  • What is Altimmune TTM net profit?
  • What is the all time high TTM net income for Altimmune?
  • What is Altimmune TTM net income year-on-year change?

What is Altimmune annual net profit?

The current annual net income of ALT is -$88.45 M

What is the all time high annual net income for Altimmune?

Altimmune all-time high annual net profit is $277.30 K

What is Altimmune annual net income year-on-year change?

Over the past year, ALT annual net profit has changed by -$3.73 M (-4.41%)

What is Altimmune quarterly net profit?

The current quarterly net income of ALT is -$22.84 M

What is the all time high quarterly net income for Altimmune?

Altimmune all-time high quarterly net profit is $1.46 M

What is Altimmune quarterly net income year-on-year change?

Over the past year, ALT quarterly net profit has changed by +$8.80 M (+27.80%)

What is Altimmune TTM net profit?

The current TTM net income of ALT is -$103.52 M

What is the all time high TTM net income for Altimmune?

Altimmune all-time high TTM net profit is $768.10 K

What is Altimmune TTM net income year-on-year change?

Over the past year, ALT TTM net profit has changed by -$15.07 M (-17.04%)